Moneycontrol Be a Pro
Get App
SENSEX NIFTY
you are here:

Ranbaxy Laboratories Ltd.

BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Apr 01, 16:00
859.90 0.00 (0.00%)
Volume
No Data Available
308,222
  • Prev. Close

    859.90

  • Open Price

    814.90

810.30

Today’s L/H

869.00
414.40

52 Wk L/H

869.00
732.70

L/U Price Band

895.50
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP
    844.65
  •  Market Depth
    BUY 0.00
    SELL 0.00
    0%
    0%
Ranbaxy Laboratories is not traded on BSE in the last 30 days

NSE Live

Apr 01, 15:59
859.80 0.00 (0.00%)
Volume
No Data Available
5,415,702
  • Prev. Close

    859.80

  • Open Price

    814.70

809.45

Today’s L/H

869.70
371.50

52 Wk L/H

869.70
33.25

L/U Price Band

36.75
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    859.80 (9924)

  • VWAP
    847.00
    Series: NA
  • DELIVERY AVERAGES
    3-Day
    43.73%
    5-Day
    48.62%
    8-Day
    51.80%
    Deliverables
  • SMA VOLUME
    30
    50
    150
    200
    SMA
Ranbaxy Laboratories is not traded on NSE in the last 30 days

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

Valuation

    • Market Cap (Rs Cr.)
      36,602.80
    • P/E
      -
    • Book Value (Rs)
      25.79
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      31.17
    • EPS (TTM)
      -
    • P/C
      253.63
    • Price/Book
      33.34
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      5.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      43.73
      5-Day
      48.62
      8-Day
      51.80
      41.95

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      36,602.80
    • P/E
      -
    • Book Value (Rs)
      77.61
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      31.17
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      11.08
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      5.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      43.73
      5-Day
      48.62
      8-Day
      51.80
      41.95

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Simple Moving Averages
DAYS BSE NSE
30 - -
50 - -
150 - -
200 - -
Click here to view the Open, High, Low, Close, Volume and Spread data.

Forum

Community Sentiments

Data not Available

What's your call on today?

Read 0 investor views

BUY SELL HOLD

Action in Ranbaxy Laboratories Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Oct 18, 09:15
814.90 -45.00 (-5.23%)
High 814.90
Low
Prev. Close 859.90

NSE

Oct 18, 09:15
814.70 -45.10 (-5.25%)
High 814.70
Low
Prev. Close 859.80

Financials

Income Statement

  Dec 2014 Sep 2014 Jun 2014 Mar 2014 Dec 2013
Net Sales 956.52 1,272.69 2,116.98 1,224.59 1,327.64
Other Income 17.75 20.02 25.76 636.50 20.60
PBDIT -351.51 -155.68 926.39 -37.66 -66.05
Net Profit -1,420.49 -368.26 755.12 897.86 -395.96
  Dec 2014 Sep 2014 Jun 2014 Mar 2014 Dec 2013
Net Sales 2,587.60 3,218.00 2,372.24 2,436.13 2,858.96
Other Income 10.68 17.39 25.45 23.70 35.24
PBDIT 112.90 807.11 237.88 149.14 270.34
Net Profit -1,023.61 478.17 -186.88 -80.21 -158.49

Balance Sheet

Standalone Mar 2014 Dec 2012
Total Share Capital 211.66 211.46
Networth 1,096.99 1,922.08
Total Debt 5,991.06 4,763.61
Net Block 2,012.14 1,993.53
Investments 4,080.88 3,131.17
Total Assets 7,088.06 6,685.68

Historical Prices

On
Current Price %Gain / Loss
No Record Found
On
Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11640.50 54.10 0.47
SENSEX 39224.71 172.65 0.44
NIFTY BANK 29060.80 71.35 0.25
NIFTY IT 15366.80 84.90 0.56
S&P BSE Smallcap 13098.48 184.39 1.43
Index Price Change %Chg
DAX (Oct 18) 12,663.14 8.19 0.06
FTSE (Oct 18) 7,173.33 -8.99 -0.13
Straits Times (Oct 18) 3,117.56 -8.58 -0.27
CAC (Oct 18) 5,657.31 -15.76 -0.28
SGX Nifty (Oct 18) 11,648.00 43.00 0.37

CORPORATE ACTION

Date Agenda
No Board Meetings Information is available for Ranbaxy Laboratories
Type Dividend% Ex-Dividend date
Final 40.00 Apr 28, 2011
Final 120.00 May 21, 2008
Interim 50.00 Nov 01, 2007
Interim 120.00 Apr 04, 2007
Interim 50.00 Nov 02, 2006
Ratio Announcement Date Ex-Bonus
3:5 Jul 18, 2002 Oct 01, 2002
1:1 Nov 11, 1998 Dec 01, 1998
1:2 Mar 30, 1993 Apr 23, 1993
2:3 Sep 30, 1991 Oct 18, 1991
2:5 Jul 02, 1988 -
Old FV New FV Ex-Split
10 5 Jul 25, 2005
Ratio Premium Ex-Bonus
9:100 0 Oct 18, 1991
Date Agenda
Sep 19, 2014 -
Jul 28, 2014 -
May 07, 2013 -
May 08, 2012 -
May 09, 2011 Rs.2.00 per share(40%)Dividend

Dividend Summary

Ranbaxy Laboratories has not declared any dividend for the last several years. As per the Profit & Loss account

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone September 2014 June 2014 March 2014 December 2013
Promoters 63.37 63.4 63.41 63.41
Pledged 0 0 0 0
FII/FPI 13.08 12.42 11.79 10.74
Total DII 12.57 12.02 10.75 12.68
Fin.Insts 0.07 0.22 0.38 0.29
Insurance Co 7.12 7.4 7.45 7.57
MF 1.22 0.49 0.47 0.95
Others DIIs 4.16 3.91 2.45 3.87
Others 10.99 12.16 14.06 13.17
Total 100.01 100 100.01 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Ranbaxy Labs 859.80 0.00 869.70 371.50 36598.55 6,864.94 -879.00
Sun Pharma 403.00 0.40 616.50 350.40 96693.2 10,303.21 816.60
Divis Labs 1735.15 0.65 1768.80 1214.25 46062.78 4,879.66 1,332.65
Dr Reddys Labs 2733.00 0.23 2965.20 2065.30 45407.63 10,625.50 1,277.30
Cipla 447.30 0.22 651.95 389.55 36055.85 12,374.01 1,888.41

COMPANY OVERVIEW

Ranbaxy Laboratories Ltd. is pharmaceutical company. It develops, manufactures and markets generic, branded generic, over-the-counter products, anti-retrovirals, active pharmaceutical ingredients and intermediates. Its products include simvastatin, amoxyclav potassium, isotretinion, ciprofloxacin, isotretinon, cephalexin, ketorolac tromethamine, cefaclor, clarithromycin and cefuroxime axetil. The company was founded in 1961 and is based in Gurgaon, Haryana. Ranbaxy Laboratories Ltd. operates as a subsidiary of Daiichi Sankyo Company Ltd.

COMPANY INFORMATION

  • Registered Office

  • Registrars

    • Name

      Alankit Assignment Ltd.

    • Address

      R T A Division, 1st FloorJhandewalan Extension,

    • City

      New Delhi 110055

    • State

      Delhi

    • Tel. No.

      011-51540060, 51540061, 51540062, 51540063

    • Fax No.

      011-51540064

    • Email

      nahar@alankit.com

    • Internet

  • Management

    • Name

      Designation

    • Tsutomu Une

      Chairman

    • Arun Sawhney

      Managing Director & CEO

    • Akihiro Watanabe

      Director

    • Anthony H Wild

      Director

    • Kazunori Hirokawa

      Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Ranbaxy Laboratories Ltd.

Ranbaxy Labs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 500359 and the NSE with an NSE Code of RANBAXY.

Related Searches